Taming Cell Penetrating Peptides: Never Too Old to Teach Old Dogs New Tricks

Molecular Pharmaceutics

Volumn 12, Issue 9, 2015, Pages 3105-3118

  Zhang, Qianyu ^a   Gao, Huile ^a   He, Qin ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

cell penetrating peptides (CPPs); drug delivery systems; improved efficiency; responsive; selectivity

Indexed keywords

ANION; CELL PENETRATING PEPTIDE; GALA PEPTIDE; HISTIDINE; LIPOSOME; PEPTIDE NUCLEIC ACID; PH LOW INSERTION PEPTIDE; UNCLASSIFIED DRUG; NANOPARTICLE;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ARTICLE; DRUG DELIVERY SYSTEM; DRUG SELECTIVITY; HUMAN; INTERNALIZATION; NONHUMAN; PH; PRIORITY JOURNAL; PROTEIN MOTIF; STIMULUS RESPONSE; SURFACE CHARGE; TUMOR GROWTH; TUMOR MICROENVIRONMENT; ULTRAVIOLET IRRADIATION; ADMINISTRATION AND DOSAGE; ANIMAL; CHEMISTRY; DOG; GENE VECTOR; NEOPLASMS; PROCEDURES;

ANIMALS; CELL-PENETRATING PEPTIDES; DOGS; DRUG DELIVERY SYSTEMS; GENETIC VECTORS; HUMANS; NANOPARTICLES; NEOPLASMS;

EID: 84941102169     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/acs.molpharmaceut.5b00428     Document Type: Article

References (154)

1. Frankel, A. D.; Pabo, C. O. Cellular uptake of the tat protein from human immunodeficiency virus Cell 1988, 55, 1189-1193 10.1016/0092-8674(88)90263-2
2. Richard, J. P.; Melikov, K.; Vives, E.; Ramos, C.; Verbeure, B.; Gait, M. J.; Chernomordik, L. V.; Lebleu, B. Cell-penetrating peptides. A reevaluation of the mechanism of cellular uptake J. Biol. Chem. 2003, 278 (1) 585-590 10.1074/jbc.M209548200
3. Drin, G.; Cottin, S.; Blanc, E.; Rees, A. R.; Temsamani, J. Studies on the internalization mechanism of cationic cell-penetrating peptides J. Biol. Chem. 2003, 278 (33) 31192-31201 10.1074/jbc.M303938200
4. Terrone, D.; Sang, S. L.; Roudaia, L.; Silvius, J. R. Penetratin and related cell-penetrating cationic peptides can translocate across lipid bilayers in the presence of a transbilayer potential Biochemistry 2003, 42 (47) 13787-13799 10.1021/bi035293y
5. Patel, L. N.; Zaro, J. L.; Shen, W. C. Cell penetrating peptides: intracellular pathways and pharmaceutical perspectives Pharm. Res. 2007, 24 (11) 1977-1992 10.1007/s11095-007-9303-7
6. Morris, M. C.; Depollier, J.; Mery, J.; Heitz, F.; Divita, G. A peptide carrier for the delivery of biologically active proteins into mammalian cells Nat. Biotechnol. 2001, 19, 1173-1176 10.1038/nbt1201-1173
7. Pooga, M.; Hällbrink, M.; Zorko, M.; Langel, U. Cell penetration by transportan FASEB J. 1998, 12, 67-77
8. Deshayes, S.; Morris, M. C.; Divita, G.; Heitz, F. Cell-penetrating peptides: tools for intracellular delivery of therapeutics Cell. Mol. Life Sci. 2005, 62 (16) 1839-1849 10.1007/s00018-005-5109-0
9. Watkins, C. L.; Brennan, P.; Fegan, C.; Takayama, K.; Nakase, I.; Futaki, S.; Jones, A. T. Cellular uptake, distribution and cytotoxicity of the hydrophobic cell penetrating peptide sequence PFVYLI linked to the proapoptotic domain peptide PAD J. Controlled Release 2009, 140 (3) 237-244 10.1016/j.jconrel.2009.04.028
10. Milletti, F. Cell-penetrating peptides: classes, origin, and current landscape Drug Discovery Today 2012, 17 (15-16) 850-860 10.1016/j.drudis.2012.03.002
11. Gupta, B.; Levchenko, T. S.; Torchilin, V. P. Intracellular delivery of large molecules and small particles by cell-penetrating proteins andpeptides Adv. Drug Delivery Rev. 2005, 57 (4) 637-651 10.1016/j.addr.2004.10.007
12. Stewart, K. M.; Horton, K. L.; Kelley, S. O. Cell-penetrating peptides as delivery vehicles for biology and medicine Org. Biomol. Chem. 2008, 6 (13) 2242-2255 10.1039/b719950c
13. Temsamani, J.; Vidal, P. The use of cell-penetrating peptides for drug delivery Drug Discovery Today 2004, 9 (23) 1012-1019 10.1016/S1359-6446(04)03279-9
14. Said Hassane, F.; Saleh, A. F.; Abes, R.; Gait, M. J.; Lebleu, B. Cell penetrating peptides: overview and applications to the delivery of oligonucleotides Cell. Mol. Life Sci. 2010, 67 (5) 715-26 10.1007/s00018-009-0186-0
15. Vives, E. Present and future of cell-penetrating peptide mediated delivery systems: Is the Trojan horse too wild to go only to Troy? J. Controlled Release 2005, 109 (1-3) 77-85 10.1016/j.jconrel.2005.09.032
16. Huang, Y.; Jiang, Y.; Wang, H.; Wang, J.; Shin, M. C.; Byun, Y.; He, H.; Liang, Y.; Yang, V. C. Curb challenges of the "rojan Horse" approach: Smart strategies in achieving effective yet safe cell-penetrating peptide-based drug delivery Adv. Drug Delivery Rev. 2013, 65 (10) 1299-1315 10.1016/j.addr.2012.11.007
17. Shi, N. Q.; Qi, X. R.; Xiang, B.; Zhang, Y. A survey on "rojan Horse" peptides: Opportunities, issues and controlled entry to "roy J. Controlled Release 2014, 194, 53-70 10.1016/j.jconrel.2014.08.014
18. Koren, E.; Torchilin, V. P. Cell-penetrating peptides: breaking through to the other side Trends Mol. Med. 2012, 18 (7) 385-393 10.1016/j.molmed.2012.04.012
19. Buyens, K.; De Smedt, S. C.; Braeckmans, K.; Demeester, J.; Peeters, L.; van Grunsven, L. A.; de Mollerat du Jeu, X.; Sawant, R.; Torchilin, V.; Farkasova, K.; Ogris, M.; Sanders, N. N. Liposome based systems for systemic siRNA delivery: stability in blood sets the requirements for optimal carrier design J. Controlled Release 2012, 158 (3) 362-370 10.1016/j.jconrel.2011.10.009
20. Farkhani, S. M.; Valizadeh, A.; Karami, H.; Mohammadi, S.; Sohrabi, N.; Badrzadeh, F. Cell penetrating peptides: Efficient vectors for delivery of nanoparticles, nanocarriers therapeutic and diagnostic molecules Peptides 2014, 57, 78-94 10.1016/j.peptides.2014.04.015
21. Nakase, I.; Takeuchi, T.; Tanaka, G.; Futaki, S. Methodological and cellular aspects that govern the internalization mechanisms of arginine-rich cell-penetrating peptides Adv. Drug Delivery Rev. 2008, 60 (4-5) 598-607 10.1016/j.addr.2007.10.006
22. Bechara, C.; Pallerla, M.; Zaltsman, Y.; Burlina, F.; Alves, I. D.; Lequin, O.; Sagan, S. Tryptophan within basic peptide sequences triggers glycosaminoglycan-dependent endocytosis FASEB J. 2013, 27 (2) 738-749 10.1096/fj.12-216176
23. Schröder-Borm, H.; Bakalova, R.; Andrä, J. The NK-lysin derived peptide NK-2 preferentially kills cancer cells with increased surface levels of negatively charged phosphatidylserine FEBS Lett. 2005, 579 (27) 6128-6134 10.1016/j.febslet.2005.09.084
24. Papo, N.; Seger, D.; Makovitzki, A.; Kalchenko, V.; Eshhar, Z.; Degani, H.; Shai, Y. Inhibition of Tumor Growth and Elimination of Multiple Metastasesi n Human Prostate and Breast Xenografts by Systemic Inoculation of a Host Defense-Like Lytic Peptide Cancer Res. 2006, 66 (10) 5371-5378 10.1158/0008-5472.CAN-05-4569
25. Jobin, M. L.; Alves, I. D. On the importance of electrostatic interactions between cell penetrating peptides and membranes: A pathway toward tumor cell selectivity? Biochimie 2014, 107, 154-159 10.1016/j.biochi.2014.07.022
26. Amand, H. L.; Rydberg, H. A.; Fornander, L. H.; Lincoln, P.; Nordén, B.; Esbjörner, E. K. Cell surface binding and uptake of arginine- and lysine-rich penetratin peptides in absence and presence of proteoglycans Biochim. Biophys. Acta, Biomembr. 2012, 1818 (11) 2669-2678 10.1016/j.bbamem.2012.06.006
27. Ziegler, A.; Seelig, J. Contributions of glycosaminoglycan binding and clustering to the biological uptake of the nonamphipathic cell-penetrating peptide WR9 Biochemistry 2011, 50 (21) 4650-4664 10.1021/bi1019429
28. Jobin, M. L.; Bonnafous, P.; Temsamani, H.; Dole, F.; Grélard, A.; Dufourc, E. J.; Alves, I. D. The enhanced membrane interaction and perturbation of a cell penetrating peptide in the presence of anionic lipids: Toward an understanding of its selectivity for cancer cells Biochim. Biophys. Acta, Biomembr. 2013, 1828 (6) 1457-1470 10.1016/j.bbamem.2013.02.008
29. Riedl, S.; Zweytick, D.; Lohner, K. Membrane-active host defense peptides-Challenges and perspectives for the development of novel anticancer drugs Chem. Phys. Lipids 2011, 164 (8) 766-781 10.1016/j.chemphyslip.2011.09.004
30. Kersemans, V.; Kersemans, K.; Cornelissen, B. Cell penetrating peptides for in vivo molecular imaging applications Curr. Pharm. Des. 2008, 14 (24) 2415-2447 10.2174/138161208785777432
31. Herce, H. D.; Garcia, A. E.; Cardoso, M. C. Fundamental Molecular Mechanism for the Cellular Uptake of Guanidinium-Rich Molecules J. Am. Chem. Soc. 2014, 136 (50) 17459-17467 10.1021/ja507790z
32. Takara, K.; Hatakeyama, H.; Ohga, N.; Hida, K.; Harashima, H. Design of a dual-ligand system using a specific ligand and cell penetrating peptide, resulting in a synergistic effect on selectivity and cellular uptake Int. J. Pharm. 2010, 396 (1-2) 143-148 10.1016/j.ijpharm.2010.05.002
33. Kibria, G.; Hatakeyama, H.; Ohga, N.; Hida, K.; Harashima, H. Dual-ligand modification of PEGylated liposomes shows better cell selectivity and efficient gene delivery J. Controlled Release 2011, 153 (2) 141-148 10.1016/j.jconrel.2011.03.012
34. Tang, J.; Zhang, L.; Liu, Y.; Zhang, Q.; Qin, Y.; Yin, Y.; Yuan, W.; Yang, Y.; Xie, Y.; Zhang, Z.; He, Q. Synergistic targeted delivery of payload into tumor cells by dual-ligand liposomes co-modified with cholesterol anchored transferrin and TAT Int. J. Pharm. 2013, 454 (1) 31-40 10.1016/j.ijpharm.2013.06.048
35. Zong, T.; Mei, L.; Gao, H.; Cai, W.; Zhu, P.; Shi, K.; Chen, J.; Wang, Y.; Gao, F.; He, Q. Synergistic dual-ligand doxorubicin liposomes improve targeting and therapeutic efficacy of brain glioma in animals Mol. Pharmaceutics 2014, 11 (7) 2346-2357 10.1021/mp500057n
36. Yang, Y.; Yang, Y.; Xie, X.; Wang, Z.; Gong, W.; Zhang, H.; Li, Y.; Yu, F.; Li, Z.; Mei, X. Dual-modified liposomes with a two-photon-sensitive cell penetrating peptide and NGR ligand for siRNA targeting delivery Biomaterials 2015, 48, 84-96 10.1016/j.biomaterials.2015.01.030
37. Danhier, F.; Feron, O.; Préat, V. To exploit the tumor microenvironment: Passive and active tumor targeting of nanocarriers for anti-cancer drug delivery J. Controlled Release 2010, 148 (2) 135-146 10.1016/j.jconrel.2010.08.027
38. Quail, D. F.; Joyce, J. A. Microenvironmental regulation of tumor progression and metastasis Nat. Med. 2013, 19 (11) 1423-1437 10.1038/nm.3394
39. Sawant, R. R.; Torchilin, V. P. Liposomes as "smart"pharmaceutical nanocarriers Soft Matter 2010, 6, 4026-4044 10.1039/b923535n
40. Koren, E.; Apte, A.; Jani, A.; Torchilin, V. P. Multifunctional PEGylated 2C5-immunoliposomes containing pH-sensitive bonds and TAT peptide for enhanced tumor cell internalization and cytotoxicity J. Controlled Release 2012, 160 (2) 264-273 10.1016/j.jconrel.2011.12.002
41. Kuai, R.; Yuan, W.; Li, W.; Qin, Y.; Tang, J.; Yuan, M.; Fu, L.; Ran, R.; Zhang, Z.; He, Q. Targeted Delivery of Cargoes into a Murine Solid Tumor by a Cell-Penetrating Peptide and Cleavable Poly(ethylene glycol) Comodified Liposomal Delivery System via Systemic Administration Mol. Pharmaceutics 2011, 8 (6) 2151-2161 10.1021/mp200100f
42. Hatakeyama, H.; Akita, H.; Harashima, H. A multifunctional envelope type nano device (MEND) for gene delivery to tumours based on the EPR effect: a strategy for overcoming the PEG dilemma Adv. Drug Delivery Rev. 2011, 63 (3) 152-160 10.1016/j.addr.2010.09.001
43. Zhu, L.; Kate, P.; Torchilin, V. P. Matrix metalloprotease 2-responsive multifunctional liposomal nanocarrier for enhanced tumor targeting ACS Nano 2012, 6 (4) 3491-3498 10.1021/nn300524f
44. He, L.; Lai, H.; Chen, T. Efficient delivery of payload into tumor cells in a controlled manner by TAT and thiolytic cleavable PEG co-modified liposomes Biomaterials 2015, 51, 30-42 10.1016/j.biomaterials.2015.01.063
45. Lee, E. S.; Na, K.; Bae, Y. H. Super pH-Sensitive Multifunctional Polymeric Micelle Nano Lett. 2005, 5 (2) 325-329 10.1021/nl0479987
46. Lee, E. S.; Gao, Z.; Kim, D.; Park, K.; Kwon, I. C.; Bae, Y. H. Super pH-sensitive multifunctional polymeric micelle for tumor pHespecific TAT exposure and multidrug resistance J. Controlled Release 2008, 129 (3) 228-326 10.1016/j.jconrel.2008.04.024
47. Gao, Z. G.; Tian, L.; Hu, J.; Park, I. S.; Bae, Y. H. Prevention of metastasis in a 4T1 murine breast cancer model by doxorubicin carried by folate conjugated pH sensitive polymeric micelles J. Controlled Release 2011, 152 (1) 84-89 10.1016/j.jconrel.2011.01.021
48. Hansen, M. B.; van Gaal, E.; Minten, I.; Storm, G.; van Hest, J. C.; Löwik, D. W. Constrained and UV-activatable cell-penetrating peptides for intracellular delivery of liposomes J. Controlled Release 2012, 164 (1) 87-94 10.1016/j.jconrel.2012.10.008
49. Gilar, M.; Olivova, P.; Daly, A. E.; Gebler, J. C. Two-dimensional separation of peptides using RP-RP-HPLC system with different pH in first and second separation dimensions J. Sep. Sci. 2005, 28 (14) 1694-1703 10.1002/jssc.200500116
50. Jin, E.; Zhang, B.; Sun, X.; Zhou, Z.; Ma, X.; Sun, Q.; Tang, J.; Shen, Y.; Van Kirk, E.; Murdoch, W. J.; Radosz, M. Acid-Active Cell-Penetrating Peptides for in Vivo Tumor-Targeted Drug Delivery J. Am. Chem. Soc. 2013, 135 (2) 933-940 10.1021/ja311180x
51. Li, Z. Y.; Liu, Y.; Hu, J. J.; Xu, Q.; Liu, L. H.; Jia, H. Z.; Chen, W. H.; Lei, Q.; Rong, L.; Zhang, X. Z. Stepwise-Acid-Active Multifunctional Mesoporous Silica Nanoparticles for Tumor-Specific Nucleus-Targeted Drug Delivery ACS Appl. Mater. Interfaces 2014, 6 (16) 14568-14575 10.1021/am503846p
52. Liu, Z.; Xiong, M.; Gong, J.; Zhang, Y.; Bai, N.; Luo, Y.; Li, L.; Wei, Y.; Liu, Y.; Tan, X.; Xiang, R. Legumain protease-activated TAT-liposome cargo for targeting tumours and their microenvironment Nat. Commun. 2014, 5, 4280 10.1038/ncomms5280
53. Lee, S. H.; Moroz, E.; Castagner, B.; Leroux, J. C. Activatable Cell Penetrating Peptide-Peptide Nucleic Acid Conjugate via Reduction of Azobenzene PEG Chains J. Am. Chem. Soc. 2014, 136 (37) 12868-12871 10.1021/ja507547w
54. Wender, P. A.; Mitchell, D. J.; Pattabiraman, K.; Pelkey, E. T.; Steinman, L.; Rothbard, J. B. The design, synthesis, and evaluation of molecules that enable or enhance cellular uptake: Peptoid molecular transporters Proc. Natl. Acad. Sci. U. S. A. 2000, 97 (24) 13003-13008 10.1073/pnas.97.24.13003
55. Nakase, I.; Niwa, M.; Takeuchi, T.; Sonomura, K.; Kawabata, N.; Koike, Y.; Takehashi, M.; Tanaka, S.; Ueda, K.; Simpson, J. C.; Jones, A. T.; Sugiura, Y.; Futaki, S. Cellular Uptake of Arginine-Rich Peptides: Roles for Macropinocytosis and Actin Rearrangement Mol. Ther. 2004, 10 (6) 1011-1022 10.1016/j.ymthe.2004.08.010
56. Amand, H. L.; Fant, K.; Nordén, B.; Esbjörner, E. K. Stimulated endocytosis in penetratin uptake: effect of arginine and lysine Biochem. Biophys. Res. Commun. 2008, 371 (4) 621-625 10.1016/j.bbrc.2008.04.039
57. Kamide, K.; Nakakubo, H.; Uno, S.; Fukamizu, A. Isolation of novel cell-penetrating peptides from a random peptide library using in vitro virus and their modifications Int. J. Mol. Med. 2010, 25 (1) 41-51 10.3892/ijmm-00000311
58. Song, J.; Kai, M.; Zhang, W.; Zhang, J.; Liu, L.; Zhang, B.; Liu, X.; Wang, R. Cellular uptake of transportan 10 and its analogs in live cells: Selectivity and structure-activity relationship studies Peptides 2011, 32 (9) 1934-1941 10.1016/j.peptides.2011.07.018
59. Rizzuti, M.; Nizzardo, M.; Zanetta, C.; Ramirez, A.; Corti, S. Therapeutic applications of the cell-penetrating HIV-1 Tat peptide Drug Discovery Today 2015, 20 (1) 76-85 10.1016/j.drudis.2014.09.017
60. Grunwald, J.; Rejtar, T.; Sawant, R.; Wang, Z.; Torchilin, V. P. TAT peptide and its conjugates: proteolytic stability Bioconjugate Chem. 2009, 20 (8) 1531-1537 10.1021/bc900081e
61. Elmquist, A.; Langel, U. In vitro uptake and stability study of pVEC and its all-D analog Biol. Chem. 2003, 384 (3) 387-393 10.1515/BC.2003.044
62. Pujals, S.; Sabidó, E.; Tarragó, T.; Giralt, E. All-D proline-rich cellpenetrating peptides: a preliminary in vivo internalization study Biochem. Soc. Trans. 2007, 35 (4) 794-796 10.1042/BST0350794
63. Verdurmen, W. P.; Bovee-Geurts, P. H.; Wadhwani, P.; Ulrich, A. S.; Hällbrink, M.; van Kuppevelt, T. H.; Brock, R. Preferential Uptake of L- versus D-Amino Acid Cell-Penetrating Peptides in a Cell Type-Dependent Manner Chem. Biol. 2011, 18 (8) 1000-1010 10.1016/j.chembiol.2011.06.006
64. Montrose, K.; Yang, Y.; Sun, X.; Wiles, S.; Krissansen, G. W. Xentry, a new class of cell-penetrating peptide uniquely equipped for delivery of drugs Sci. Rep. 2013, 3, 1661 10.1038/srep01661
65. Nakase, I.; Konishi, Y.; Ueda, M.; Saji, H.; Futaki, S. Accumulation of arginine-rich cell-penetrating peptides in tumors and the potential for anticancer drug deliveryin vivo J. Controlled Release 2012, 159 (2) 181-188 10.1016/j.jconrel.2012.01.016
66. Yao, X.; Chen, L.; Chen, X.; He, C.; Zheng, H.; Chen, X. Intercellular pH-responsive histidine modified dextran-g-cholesterol micelle for anticancer drug delivery Colloids Surf., B 2014, 121, 36-43 10.1016/j.colsurfb.2014.05.032
67. Toriyabe, N.; Hayashi, Y.; Harashima, H. The transfection activity of R8-modified nanoparticles and siRNA condensation using pH sensitive stearylated-octa histidine Biomaterials 2013, 34, 1337-1343 10.1016/j.biomaterials.2012.10.043
68. Wu, H.; Zhu, L.; Torchilin, V. P. pH-sensitive poly(histidine)-PEG/DSPE-PEG co polymer micelles for cytosolic drug delivery Biomaterials 2013, 34, 1213-1222 10.1016/j.biomaterials.2012.08.072
69. Tian, L.; Bae, Y. H. Cancer nanomedicines targeting tumor extracellular pH Colloids Surf., B 2012, 99, 116-126 10.1016/j.colsurfb.2011.10.039
70. Wen, Y.; Guo, Z.; Du, Z.; Fang, R.; Wu, H.; Zeng, X.; Wang, C.; Feng, M.; Pan, S. Serum tolerance and endosomal escape capacity of histidine-modified pDNA-loaded complexes based on polyamidoamine dendrimer derivatives Biomaterials 2012, 33 (32) 8111-8121 10.1016/j.biomaterials.2012.07.032
71. Cai, X.; Zhu, H.; Dong, H.; Li, Y.; Su, J.; Shi, D. Suppression of VEGF by reversible-PEGylated histidylated polylysine in cancer therapy Adv. Healthcare Mater. 2014, 3 (11) 1818-1827 10.1002/adhm.201400063
72. Zhang, W.; Song, J.; Zhang, B.; Liu, L.; Wang, K.; Wang, R. Design of acid-activated cell penetrating peptide for delivery of active molecules into cancer cells Bioconjugate Chem. 2011, 22, 1410-1415 10.1021/bc200138d
73. Zhang, Q.; Tang, J.; Fu, L.; Ran, R.; Liu, Y.; Yuan, M.; He, Q. A pH-responsive α-helical cell penetrating peptide-mediated liposomal delivery system Biomaterials 2013, 34, 7980-7993 10.1016/j.biomaterials.2013.07.014
74. Tu, Z.; Volk, M.; Shah, K.; Clerkin, K.; Liang, J. F. Constructing bioactive peptides with pH dependent activities Peptides 2009, 30, 1523-1528 10.1016/j.peptides.2009.05.009
75. Li, L.; He, J.; Eckert, R.; Yarbrough, D.; Lux, R.; Anderson, M.; Shi, W. Design and characterization of an acid-activated antimicrobial peptide Chem. Biol. Drug Des. 2010, 75, 127-132 10.1111/j.1747-0285.2009.00904.x
76. Makovitzki, A.; Fink, A.; Shai, Y. Suppression of human solid tumor growth in mice by intratumor and systemic inoculation of histidine-rich and pH-dependent host defense-like lytic peptides Cancer Res. 2009, 69, 3458-3463 10.1158/0008-5472.CAN-08-3021
77. Midoux, P.; Kichler, A.; Boutin, V.; Maurizot, J. C.; Monsigny, M. Membrane permeabilization and efficient gene transfer by a peptide containing several histidines Bioconjugate Chem. 1998, 9 (2) 260-267 10.1021/bc9701611
78. Kichler, A.; Mason, A. J.; Bechinger, B. Cationic amphipathic histidine-rich peptides for gene delivery Biochim. Biophys. Acta, Biomembr. 2006, 1758 (3) 301-317 10.1016/j.bbamem.2006.02.005
79. Tanaka, K.; Kanazawa, T.; Horiuchi, S.; Ando, T.; Sugawara, K.; Takashima, Y.; Seta, Y.; Okada, H. Cytoplasm-responsive nanocarriers conjugated with a functional cell-penetrating peptide for systemic siRNA delivery Int. J. Pharm. 2013, 455 (1-2) 40-47 10.1016/j.ijpharm.2013.07.069
80. Jiang, T.; Zhang, Z.; Zhang, Y.; Lv, H.; Zhou, J.; Li, C.; Hou, L.; Zhang, Q. Dual-functional liposomes based on pH-responsive cell-penetrating peptide and hyaluronic acid for tumor-targeted anticancer drug delivery Biomaterials 2012, 33, 9246-9258 10.1016/j.biomaterials.2012.09.027
81. Zhao, B. X.; Zhao, Y.; Huang, Y.; Luo, L. M.; Song, P.; Wang, X.; Chen, S.; Yu, K. F.; Zhang, X.; Zhang, Q. The efficiency of tumor-specific pH-responsive peptide-modified polymeric micelles containing paclitaxel Biomaterials 2012, 33, 2508-2520 10.1016/j.biomaterials.2011.11.078
82. Jiang, T.; Olson, E. S.; Nguyen, Q. T.; Roy, M.; Jennings, P. A.; Tsien, R. Y. Tumor imaging by means of proteolytic activation of cell-penetrating peptides Proc. Natl. Acad. Sci. U. S. A. 2004, 101 (51) 17867-17872 10.1073/pnas.0408191101
83. Aguilera, T. A.; Olson, E. S.; Timmers, M. M.; Jiang, T.; Tsien, R. Y. Systemic in vivo distribution of activatable cell penetrating peptides is superior to cell penetrating peptides Integr Biol. (Camb). 2009, 1 (5-6) 371-381 10.1039/b904878b
84. Olson, E. S.; Aguilera, T. A.; Jiang, T.; Ellies, L. G.; Nguyen, Q. T.; Wong, E. H.; Gross, L. A.; Tsien, R. Y. In vivo characterization of activatable cell penetrating peptides for targeting protease activity in cancer Integr Biol. (Camb). 2009, 1 (5-6) 382-393 10.1039/b904890a
85. Olson, E. S.; Jiang, T.; Aguilera, T. A.; Nguyen, Q. T.; Ellies, L. G.; Scadeng, M.; Tsien, R. Y. Activatable cell penetrating peptides linked to nanoparticles as dual probes for in vivo fluorescence and MR imaging of proteases Proc. Natl. Acad. Sci. U. S. A. 2010, 107 (9) 4311-4316 10.1073/pnas.0910283107
86. Huang, S.; Shao, K.; Liu, Y.; Kuang, Y.; Li, J.; An, S.; Guo, Y.; Ma, H.; Jiang, C. Tumor-Targeting and Microenvironment-Responsive Smart Nanoparticles for Combination Therapy of Antiangiogenesis and Apoptosis ACS Nano 2013, 7 (3) 2860-2871 10.1021/nn400548g
87. Gao, H.; Zhang, S.; Cao, S.; Yang, Z.; Pang, Z.; Jiang, X. Angiopep-2 and Activatable Cell-Penetrating Peptide DualFunctionalized Nanoparticles for Systemic Glioma-Targeting Delivery Mol. Pharmaceutics 2014, 11 (8) 2755-2763 10.1021/mp500113p
88. van Duijnhoven, S. M.; Robillard, M. S.; Hermann, S.; Kuhlmann, M. T.; Schäfers, M.; Nicolay, K.; Grüll, H. Imaging of MMP Activity in Postischemic Cardiac Remodeling Using Radiolabeled MMP-2/9 Activatable Peptide Probes Mol. Pharmaceutics 2014, 11 (5) 1415-1423 10.1021/mp400569k
89. van Duijnhoven, S. M.; Robillard, M. S.; Nicolay, K.; Grüll, H. Tumor targeting of MMP-2/9 activatable cell-penetrating imaging probes is caused by tumor-independent activation J. Nucl. Med. 2011, 52 (2) 279-286 10.2967/jnumed.110.082503
90. Nguyen, Q. T.; Olson, E. S.; Aguilera, T. A.; Jiang, T.; Scadeng, M.; Ellies, L. G.; Tsien, R. Y. Surgery with molecular fluorescence imaging using activatable cell-penetrating peptides decreases residual cancer and improves survival Proc. Natl. Acad. Sci. U. S. A. 2010, 107 (9) 4317-4322 10.1073/pnas.0910261107
91. Metildi, C. A.; Felsen, C. N.; Savariar, E. N.; Nguyen, Q. T.; Kaushal, S.; Hoffman, R. M.; Tsien, R. Y.; Bouvet, M. Fluorescence-guided surgery of pancreatic cancer using activatable cell penetrating peptides (ACPPs) in orthotopic mouse models Ann. Surg Oncol. 2015, 22 (6) 2082-2087 10.1245/s10434-014-4144-1
92. Savariar, E. N.; Felsen, C. N.; Nashi, N.; Jiang, T.; Ellies, L. G.; Steinbach, P.; Tsien, R. Y.; Nguyen, Q. T. Real-time In Vivo Molecular Detection of Primary Tumors and Metastases with Ratiometric Activatable Cell-Penetrating Peptides Cancer Res. 2013, 73 (2) 855-864 10.1158/0008-5472.CAN-12-2969
93. Ren, Y.; Hauert, S.; Lo, J. H.; Bhatia, S. N. Identification and Characterization of Receptor-Specific Peptides for siRNA Delivery ACS Nano 2012, 6 (10) 8620-8631 10.1021/nn301975s
94. Karagiannis, E. D.; Alabi, C. A.; Anderson, D. G. Rationally Designed Tumor-Penetrating Nanocomplexes ACS Nano 2012, 6 (10) 8484-8487 10.1021/nn304707b
95. Gong, C.; Li, X.; Xu, L.; Zhang, Y. H. Target delivery of a gene into the brain using the RVG29-oligoarginine peptide Biomaterials 2012, 33 (12) 3456-3463 10.1016/j.biomaterials.2011.12.017
96. Youn, P.; Chen, Y.; Furgeson, D. Y. A Myristoylated Cell-Penetrating Peptide Bearing a Transferrin Receptor-Targeting Sequence for Neuro-Targeted siRNA Delivery Mol. Pharmaceutics 2014, 11 (2) 486-495 10.1021/mp400446v
97. Svensen, N.; Walton, J. G.; Bradley, M. Peptides for cell-selective drug delivery Trends Pharmacol. Sci. 2012, 33 (4) 186-192 10.1016/j.tips.2012.02.002
98. Myrberg, H.; Zhang, L.; Mäe, M.; Langel, U. Design of a Tumor-Homing Cell-Penetrating Peptide Bioconjugate Chem. 2008, 19 (1) 70-75 10.1021/bc0701139
99. Liu, Y.; Ran, R.; Chen, J.; Kuang, Q.; Tang, J.; Mei, L.; Zhang, Q.; Gao, H.; Zhang, Z.; He, Q. Paclitaxel loaded liposomes decorated with a multifunctional tandem peptide for glioma targeting Biomaterials 2014, 35 (17) 4835-4847 10.1016/j.biomaterials.2014.02.031
100. Kang, M. H.; Park, M. J.; Yoo, H. J.; Hyuk, K. Y.; Lee, S. G.; Kim, S. R.; Yeom, D. W.; Kang, M. J.; Choi, Y. W. RIPL peptide (IPLVVPLRRRRRRRRC)-conjugated liposomes for enhanced intracellular drug delivery to hepsin-expressing cancer cells Eur. J. Pharm. Biopharm. 2014, 87 (3) 489-499 10.1016/j.ejpb.2014.03.016
101. Wadia, J. S.; Stan, R. V.; Dowdy, S. F. Transducible TAT-HA fusogenic peptide enhances escape of TAT-fusion proteins after lipid raft macropinocytosis Nat. Med. 2004, 10, 310-315 10.1038/nm996
102. Ye, S. F.; Tian, M. M.; Wang, T. X.; Ren, L.; Wang, D.; Shen, L. H.; Shang, T. Synergistic effects of cell-penetrating peptide Tat and fusogenic peptide HA2-enhanced cellular internalization and gene transduction of organosilica nanoparticles Nanomedicine 2012, 8 (6) 833-841 10.1016/j.nano.2011.10.003
103. Salomone, F.; Cardarelli, F.; Di Luca, M.; Boccardi, C.; Nifosì, R.; Bardi, G.; Di Bari, L.; Serresi, M.; Beltram, F. A novel chimeric cell-penetrating peptide with membrane-disruptive properties for efficient endosomal escape J. Controlled Release 2012, 163 (3) 293-303 10.1016/j.jconrel.2012.09.019
104. El-Sayed, A.; Futaki, S.; Harashima, H. Delivery of Macromolecules Using Arginine-Rich Cell-Penetrating Peptides: Ways to Overcome Endosomal Entrapment AAPS J. 2009, 11 (1) 13-22 10.1208/s12248-008-9071-2
105. Lo, S. L.; Wang, S. An endosomolytic Tat peptide produced by incorporation of histidine and cysteine residues as a nonviral vector for DNA transfection Biomaterials 2008, 29 (15) 2408-2414 10.1016/j.biomaterials.2008.01.031
106. Kondo, E.; Saito, K.; Tashiro, Y.; Kamide, K.; Uno, S.; Furuya, T.; Mashita, M.; Nakajima, K.; Tsumuraya, T.; Kobayashi, N.; Nishibori, M.; Tanimoto, M.; Matsushita, M. Tumour lineage-homing cell-penetrating peptides as anticancer molecular delivery systems Nat. Commun. 2012, 3, 951 10.1038/ncomms1952
107. Higa, M.; Katagiri, C.; Shimizu-Okabe, C.; Tsumuraya, T.; Sunagawa, M.; Nakamura, M.; Ishiuchi, S.; Takayama, C.; Kondo, E.; Matsushita, M. Identification of a novel cell-penetrating peptide targeting human glioblastoma cell lines as a cancer-homing transporter Biochem. Biophys. Res. Commun. 2015, 457 (2) 206-212 10.1016/j.bbrc.2014.12.089
108. Gao, H.; Zhang, Q.; Yang, Y.; Jiang, X.; He, Q. Tumor homing cell penetrating peptide decorated nanoparticles used for enhancing tumor targeting delivery and therapy Int. J. Pharm. 2015, 478 (1) 240-250 10.1016/j.ijpharm.2014.11.029
109. Jones, A. T.; Sayers, E. J. Cell entry of cell penetrating peptides: tales of tails wagging dogs J. Controlled Release 2012, 161 (2) 582-591 10.1016/j.jconrel.2012.04.003
110. Raghuraman, H.; Chattopadhyay, A. Melittin: a membrane-active peptide with diverse functions Biosci. Rep. 2007, 27 (4-5) 189-223 10.1007/s10540-006-9030-z
111. Kaiser, E. T.; Kézdy, F. J. Peptides with affinity for membranes Annu. Rev. Biophys. Biophys. Chem. 1987, 16, 561-581 10.1146/annurev.bb.16.060187.003021
112. Ferrer-Miralles, N.; Vázquez, E.; Villaverde, A. Membrane-active peptides for non-viral gene therapy: making the safest easier Trends Biotechnol. 2008, 26 (5) 267-275 10.1016/j.tibtech.2008.02.003
113. Henriques, S. T.; Melo, M. N.; Castanho, M. A. Cell-penetrating peptides and antimicrobial peptides: how different are they? Biochem. J. 2006, 399 (1) 1-7 10.1042/BJ20061100
114. Wadhwani, P.; Reichert, J.; Bürck, J.; Ulrich, A. S. Antimicrobial and cell-penetrating peptides induce lipid vesicle fusion by folding and aggregation Eur. Biophys. J. 2012, 41 (2) 177-187 10.1007/s00249-011-0771-7
115. Zhang, Q.; Ran, R.; Zhang, L.; Liu, Y.; Mei, L.; Zhang, Z.; Gao, H.; He, Q. Simultaneous delivery of therapeutic antagomirs with paclitaxel for the management of metastatic tumors by a pH-responsive anti-microbial peptide-mediated liposomal delivery system J. Controlled Release 2015, 197, 208-218 10.1016/j.jconrel.2014.11.010
116. Zhang, Q.; Tang, J.; Ran, R.; Liu, Y.; Zhang, Z.; Gao, H.; He, Q. Development of an anti-microbial peptide-mediated liposomal delivery system: a novel approach towards pH-responsive anti-microbial peptides Drug Delivery 2015, 19, 1-8 10.3109/10717544.2014.1003665
117. Subbarao, N. K.; Parente, R. A.; Szoka, F. C., Jr.; Nadasdi, L.; Pongracz, K. pH-dependent bilayer destabilization by an amphipathic peptide Biochemistry 1987, 26 (11) 2964-2972 10.1021/bi00385a002
118. Parente, R. A.; Nir, S.; Szoka, F. C., Jr. pH-dependent fusion of phosphatidylcholine small vesicles. Induction by a synthetic amphipathic peptide J. Biol. Chem. 1988, 263 (10) 4724-4730
119. Li, W.; Nicol, F.; Szoka, F. C., Jr. GALA: a designed synthetic pH-responsive amphipathic peptide with applications in drug and gene delivery Adv. Drug Delivery Rev. 2004, 56 (7) 967-985 10.1016/j.addr.2003.10.041
120. Kakudo, T.; Chaki, S.; Futaki, S.; Nakase, I.; Akaji, K.; Kawakami, T.; Maruyama, K.; Kamiya, H.; Harashima, H. Transferrin-modified liposomes equipped with a pH-sensitive fusogenic peptide: an artificial viral-like delivery system Biochemistry 2004, 43 (19) 5618-5628 10.1021/bi035802w
121. Sasaki, K.; Kogure, K.; Chaki, S.; Nakamura, Y.; Moriguchi, R.; Hamada, H.; Danev, R.; Nagayama, K.; Futaki, S.; Harashima, H. An artificial virus-like nano carrier system: enhanced endosomal escape of nanoparticles via synergistic action of pH-sensitive fusogenic peptide derivatives Anal. Bioanal. Chem. 2008, 391 (8) 2717-2727 10.1007/s00216-008-2012-1
122. Hatakeyama, H.; Ito, E.; Akita, H.; Oishi, M.; Nagasaki, Y.; Futaki, S.; Harashima, H. A pH-sensitive fusogenic peptide facilitates endosomal escape and greatly enhances the gene silencing of siRNA-containing nanoparticles in vitro and in vivo J. Controlled Release 2009, 139 (2) 127-132 10.1016/j.jconrel.2009.06.008
123. McCarthy, H. O.; McCaffrey, J.; McCrudden, C. M.; Zholobenko, A.; Ali, A. A.; McBride, J. W.; Massey, A. S.; Pentlavalli, S.; Chen, K. H.; Cole, G.; Loughran, S. P.; Dunne, N. J.; Donnelly, R. F.; Kett, V. L.; Robson, T. Development and characterization of self-assembling nanoparticles using a bio-inspired amphipathic peptide for gene delivery J. Controlled Release 2014, 189, 141-149 10.1016/j.jconrel.2014.06.048
124. Shaheen, S. M.; Akita, H.; Nakamura, T.; Takayama, S.; Futaki, S.; Yamashita, A.; Katoono, R.; Yui, N.; Harashima, H. KALA-modified multi-layered nanoparticles as gene carriers for MHC class-I mediated antigen presentation for a DNA vaccine Biomaterials 2011, 32 (26) 6342-6350 10.1016/j.biomaterials.2011.05.014
125. Nouri, F. S.; Wang, X.; Dorrani, M.; Karjoo, Z.; Hatefi, A. A Recombinant Biopolymeric Platform for Reliable Evaluation of the Activity of pH-Responsive Amphiphile Fusogenic Peptides Biomacromolecules 2013, 14 (6) 2033-2040 10.1021/bm400380s
126. Kusumoto, K.; Akita, H.; Ishitsuka, T.; Matsumoto, Y.; Nomoto, T.; Furukawa, R.; El-Sayed, A.; Hatakeyama, H.; Kajimoto, K.; Yamada, Y.; Kataoka, K.; Harashima, H. Lipid Envelope-Type Nanoparticle Incorporating a Multifunctional Peptide for Systemic siRNA Delivery to the Pulmonary Endothelium ACS Nano 2013, 7 (9) 7534-7541 10.1021/nn401317t
127. Hunt, J. F.; Rath, P.; Rothschild, K. J.; Engelman, D. M. Spontaneous, pH-Dependent Membrane Insertion of a Transbilayer α-Helix Biochemistry 1997, 36 (49) 15177-15192 10.1021/bi970147b
128. Andreev, O. A.; Engelman, D. M.; Reshetnyak, Y. K. pH-sensitive membrane peptides (pHLIPs) as a novel class of delivery agents Mol. Membr. Biol. 2010, 27 (7) 341-352 10.3109/09687688.2010.509285
129. Yao, L.; Daniels, J.; Moshnikova, A.; Kuznetsov, S.; Ahmed, A.; Engelman, D. M.; Reshetnyak, Y. K.; Andreev, O. A. pHLIP peptide targets nanogold particles to tumors Proc. Natl. Acad. Sci. U. S. A. 2013, 110 (2) 465-470 10.1073/pnas.1219665110
130. Weerakkody, D.; Moshnikova, A.; Thakur, M. S.; Moshnikova, V.; Daniels, J.; Engelman, D. M.; Andreev, O. A.; Reshetnyak, Y. K. Family of pH (low) insertion peptides for tumor targeting Proc. Natl. Acad. Sci. U. S. A. 2013, 110 (15) 5834-5839 10.1073/pnas.1303708110
131. Musial-Siwek, M.; Karabadzhak, A.; Andreev, O. A.; Reshetnyak, Y. K.; Engelman, D. M. Tuning the insertion properties of pHLIP Biochim. Biophys. Acta, Biomembr. 2010, 1798 (6) 1041-1046 10.1016/j.bbamem.2009.08.023
132. Andreev, O. A.; Dupuy, A. D.; Segala, M.; Sandugu, S.; Serra, D. A.; Chichester, C. O.; Engelman, D. M.; Reshetnyak, Y. K. Mechanism and uses of a peptide that targets tumors and other acidic tissue in vivo Proc. Natl. Acad. Sci. U. S. A. 2007, 104 (19) 7893-7898 10.1073/pnas.0702439104
133. Vavere, A. L.; Biddlecombe, G. B.; Spees, W. M.; Garbow, J. R.; Wijesinghe, D.; Andreev, O. A.; Engelman, D. M.; Reshetnyak, Y. K.; Lewis, J. S. A novel technology for the imaging of acidic prostate tumors by positron emission tomography Cancer Res. 2009, 69 (10) 4510-4516 10.1158/0008-5472.CAN-08-3781
134. Andreev, O. A.; Engelman, D. M.; Reshetnyak, Y. K. Targeting acidic diseased tissue: New technology based on use of the pH (Low) Insertion Peptide (pHLIP) Chim. Oggi 2009, 27 (2) 34-37
135. Yao, L.; Daniels, J.; Wijesinghe, D.; Andreev, O. A.; Reshetnyak, Y. K. pHLIP®-mediated delivery of PEGylated liposomes to cancer cells J. Controlled Release 2013, 167 (3) 228-237 10.1016/j.jconrel.2013.01.037
136. Deacon, J. C.; Engelman, D. M.; Barrera, F. N. Targeting acidity in diseased tissues: Mechanism and applications of the membrane-inserting peptide, pHLIP Arch. Biochem. Biophys. 2015, 565, 40-48 10.1016/j.abb.2014.11.002
137. Teesalu, T.; Sugahara, K. N.; Kotamraju, V. R.; Ruoslahti, E. C-end rule peptides mediate neuropilin-1-dependent cell, vascular, and tissue penetration Proc. Natl. Acad. Sci. U. S. A. 2009, 106 (38) 16157-16162 10.1073/pnas.0908201106
138. Feron, O. Tumor-penetrating peptides: a shift from magic bullets to magic guns Sci. Transl. Med. 2010, 2 (34) 34ps26 10.1126/scitranslmed.3001174
139. Sugahara, K. N.; Teesalu, T.; Karmali, P. P.; Kotamraju, V. R.; Agemy, L.; Greenwald, D. R.; Ruoslahti, E. Coadministration of a tumor-penetrating peptide enhances the efficacy of cancer drugs Science 2010, 328 (5981) 1031-1035 10.1126/science.1183057
140. Teesalu, T.; Sugahara, K. N.; Ruoslahti, E. Tumor-penetrating peptides Front. Oncol. 2013, 3, 216 10.3389/fonc.2013.00216
141. Sugahara, K. N.; Teesalu, T.; Karmali, P. P.; Kotamraju, V. R.; Agemy, L.; Girard, O. M.; Hanahan, D.; Mattrey, R. F.; Ruoslahti, E. Tissue-Penetrating Delivery of Compounds and Nanoparticles into Tumors Cancer Cell 2009, 16 (6) 510-520 10.1016/j.ccr.2009.10.013
142. Alberici, L.; Roth, L.; Sugahara, K. N.; Agemy, L.; Kotamraju, V. R.; Teesalu, T.; Bordignon, C.; Traversari, C.; Rizzardi, G. P.; Ruoslahti, E. De Novo Design of a Tumor-Penetrating Peptide Cancer Res. 2013, 73 (2) 804-812 10.1158/0008-5472.CAN-12-1668
143. Wang, K.; Zhang, X.; Liu, Y.; Liu, C.; Jiang, B.; Jiang, Y. Tumor penetrability and anti-angiogenesis using iRGD-mediated delivery of doxorubicin-polymer conjugates Biomaterials 2014, 35 (30) 8735-8747 10.1016/j.biomaterials.2014.06.042
144. Kang, T.; Gao, X.; Hu, Q.; Jiang, D.; Feng, X.; Zhang, X.; Song, Q.; Yao, L.; Huang, M.; Jiang, X.; Pang, Z.; Chen, H.; Chen, J. iNGR-modified PEG-PLGA nanoparticles that recognize tumor vasculature and penetrate gliomas Biomaterials 2014, 35 (14) 4319-4332 10.1016/j.biomaterials.2014.01.082
145. Zhao, C.; Liu, X.; Liu, J.; Yang, Z.; Rong, X.; Li, M.; Liang, X.; Wu, Y. Targeting peptide iRGD-conjugated amphiphilic chitosan-co-PLA/DPPE drug delivery system for ennced tumor therapy Colloids Surf., B 2014, 123, 787-796 10.1016/j.colsurfb.2014.10.024
146. Li, M.; Tang, Z.; Zhang, D.; Sun, H.; Liu, H.; Zhang, Y.; Zhang, Y.; Chen, X. Doxorubicin-loaded polysaccharide nanoparticles suppress the growth of murine colorectal carcinoma and inhibit the metastasis of murine mammary carcinoma in rodent models Biomaterials 2015, 51, 161-172 10.1016/j.biomaterials.2015.02.002
147. Sugahara, K. N.; Braun, G. B.; de Mendoza, T. H.; Kotamraju, V. R.; French, R. P.; Lowy, A. M.; Teesalu, T.; Ruoslahti, E. Tumor-Penetrating iRGD Peptide Inhibits Metastasis Mol. Cancer Ther. 2015, 14 (1) 120-128 10.1158/1535-7163.MCT-14-0366
148. Paoli, E. E.; Ingham, E. S.; Zhang, H.; Mahakian, L. M.; Fite, B. Z.; Gagnon, M. K.; Tam, S.; Kheirolomoom, A.; Cardiff, R. D.; Ferrara, K. W. Accumulation, internalization and therapeutic efficacy of neuropilin-1-targeted liposomes J. Controlled Release 2014, 178, 108-117 10.1016/j.jconrel.2014.01.005
149. Wang, J.; Lei, Y.; Xie, C.; Lu, W.; Wagner, E.; Xie, Z.; Gao, J.; Zhang, X.; Yan, Z.; Liu, M. Retro-Inverso CendR Peptide-Mediated Polyethyleneimine for Intracranial Glioblastoma-Targeting Gene Therapy Bioconjugate Chem. 2014, 25 (2) 414-423 10.1021/bc400552t
150. Roth, L.; Agemy, L.; Kotamraju, V. R.; Braun, G.; Teesalu, T.; Sugahara, K. N.; Hamzah, J.; Ruoslahti, E. Transtumoral targeting enabled by a novel neuropilin-binding peptide Oncogene 2012, 31 (33) 3754-3763 10.1038/onc.2011.537
151. Hu, Q.; Gu, G.; Liu, Z.; Jiang, M.; Kang, T.; Miao, D.; Tu, Y.; Pang, Z.; Song, Q.; Yao, L.; Xia, H.; Chen, H.; Jiang, X.; Gao, X.; Chen, J. F3 peptide-functionalized PEG-PLA nanoparticles co-administrated with tLyp-1 peptide for anti-glioma drug delivery Biomaterials 2013, 34 (4) 1135-1145 10.1016/j.biomaterials.2012.10.048
152. Wang, J.; Lei, Y.; Xie, C.; Lu, W.; Yan, Z.; Gao, J.; Xie, Z.; Zhang, X.; Liu, M. Targeted gene delivery to glioblastoma using a C-end rule RGERPPR peptide-functionalised polyethylenimine complex Int. J. Pharm. 2013, 458 (1) 48-56 10.1016/j.ijpharm.2013.10.017
153. Pang, H. B.; Braun, G. B.; Friman, T.; Aza-Blanc, P.; Ruidiaz, M. E.; Sugahara, K. N.; Teesalu, T.; Ruoslahti, E. An endocytosis pathway initiated through neuropilin-1 and regulated by nutrient availability Nat. Commun. 2014, 5, 4904 10.1038/ncomms5904
154. Vasconcelos, L.; Pärn, K.; Langel, U. Therapeutic potential of cell-penetrating peptides Ther. Delivery 2013, 4 (5) 573-591 10.4155/tde.13.22